Olaparib for maintenance treatment of relapsed, platinum-sensitive ovarian, fallopian tube or peritoneal cancer after 2 or more courses of platinum-based chemotherapy
Technology appraisal guidance
Reference number: TA908
Published:
Evidence
Documents containing the evidence that was used to develop the recommendations.